Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways

Title
Urolithin A suppresses RANKL-induced osteoclastogenesis and postmenopausal osteoporosis by, suppresses inflammation and downstream NF-κB activated pyroptosis pathways
Authors
Keywords
Urolithin A, Osteoporosis, Osteoclast, Inflammation, Pyroptosis
Journal
PHARMACOLOGICAL RESEARCH
Volume 174, Issue -, Pages 105967
Publisher
Elsevier BV
Online
2021-11-03
DOI
10.1016/j.phrs.2021.105967

Ask authors/readers for more resources

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started